Skip to content 
This represents a major shift from the emergency vaccination campaigns of the early pandemic.
Vaccination is increasingly being integrated into routine, risk-based health care.
## Variants Are Part of the Story
SARS-CoV-2 has never been a static virus.
Like other viruses, it changes genetically as it spreads.
Some mutations have little practical significance. Others can affect how efficiently the virus spreads or how well existing immunity recognizes it.
This is why scientists continue monitoring circulating variants and periodically reassessing vaccine composition.
In May 2026, WHO’s Technical Advisory Group on COVID-19 Vaccine Composition recommended a monovalent LP.8.1 antigen for updated vaccines, while noting that other approaches capable of generating broad protection could also be used. Organisation mondiale de la santé
The lesson is important: vaccine development did not end when the first vaccines arrived.
Scientists have had to keep adapting to an evolving virus.
## Long COVID Remains One of the Biggest Unanswered Questions
Perhaps the most important reminder that the pandemic is not simply history is **long COVID**, also known as post-COVID-19 condition.
Most people recover from COVID-19, but some develop symptoms that continue or appear after their initial illness.
According to WHO, approximately six out of every 100 people who have COVID-19 develop post-COVID-19 condition. The organization notes that the risk appears lower now than earlier in the pandemic, although the virus continues to circulate and every infection carries some risk. Organisation mondiale de la santé
The symptoms can be remarkably varied.
They may include fatigue, breathlessness, muscle or joint pain, headaches, sleep problems and difficulty concentrating. More than 200 symptoms have been reported.
For some people, these problems are relatively mild.
For others, they can interfere substantially with work, exercise and everyday activities. Organisation mondiale de la santé
Scientists continue studying why some people recover quickly while others experience prolonged symptoms.
That research is important not only for COVID-19 but for our broader understanding of post-viral illness.
## We Also Know More About Treatment
Early in the pandemic, doctors were forced to treat a new disease while learning in real time.
Some approaches proved useful.
Others did not.
Over the following years, clinical trials and accumulated experience dramatically improved medical management.
Healthcare providers now have a much better understanding of which patients are at increased risk, how to monitor severe disease and when specific treatments may be appropriate.
WHO continues to update its clinical-management guidelines as new evidence emerges. Its 2025 guidance, for example, included recommendations concerning the use of antibiotics in COVID-19 patients when bacterial infection is not suspected. Organisation mondiale de la santé
That continuing process is an important lesson in modern medicine: scientific guidance is not supposed to remain frozen.
It changes as evidence improves.